E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation

Published:2022-02-09 Issue:5 Volume:25 Page:467-475
ISSN:1369-7137
Container-title:Climacteric
language:en
Short-container-title:Climacteric

Author:

Zhang L.¹,Ruan X.¹²^ORCID,Gu M.¹,Mueck A. O.¹²

Affiliation:

1. Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China

2. Department of Women’s Health, University Women's Hospital and Research Center for Women's Health, University of Tuebingen, Tuebingen, Germany

Funder

National Natural Science Foundation of China

Beijing Municipal Health Commission

Beijing Natural Science Foundation

Beijing Municipal Science & Technology Commission

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13697137.2022.2029837

Reference36 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause?

3. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study

4. Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of cancer progression by CK2: an emerging therapeutic target;Medical Oncology;2024-03-25

2. Progesterone Receptor Membrane Component 1 Regulates Cellular Stress Responses and Inflammatory Pathways in Chronic Neuroinflammatory Conditions;Antioxidants;2024-02-13

3. Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway;Journal of Translational Medicine;2024-01-03

4. Regulatory action of PGRMC1 on cyclic AMP-mediated COX2 expression in human endometrial cells;Journal of Pharmacological Sciences;2023-12

5. The WHO claims estrogens are ‘carcinogenic’: is this true?;Climacteric;2023-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3